当前位置:首页 - 行情中心 - 金河生物(002688) - 财务分析 - 现金流量表

金河生物

(002688)

  

流通市值:47.61亿  总市值:49.15亿
流通股本:7.47亿   总股本:7.72亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,041,174,742.371,279,956,215.96570,894,741.622,304,554,396.62
  收到的税费返还48,627,759.6926,662,771.8415,191,280.4375,099,520.34
  收到其他与经营活动有关的现金50,697,958.6629,341,247.537,196,239.0694,435,597.07
  经营活动现金流入小计2,140,500,460.721,335,960,235.33593,282,261.112,474,089,514.03
  购买商品、接受劳务支付的现金1,241,335,794.24843,297,950.53356,797,057.661,376,323,465.19
  支付给职工以及为职工支付的现金306,015,978.89208,030,973.13115,857,169.73362,860,922.97
  支付的各项税费86,090,163.6462,192,550.7814,827,858.4362,426,224.23
  支付其他与经营活动有关的现金142,810,938.3988,118,815.4147,980,224.55174,054,964.45
  经营活动现金流出小计1,776,252,875.161,201,640,289.85535,462,310.371,975,665,576.84
  经营活动产生的现金流量净额364,247,585.56134,319,945.4857,819,950.74498,423,937.19
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额667,030265,830.3-5,679,214.84
  处置子公司及其他营业单位收到的现金净额---892,576.01
  收到的其他与投资活动有关的现金4,000,0004,000,0004,000,00017,000,000
  投资活动现金流入小计4,667,0304,265,830.34,000,00023,571,790.85
  购建固定资产、无形资产和其他长期资产支付的现金218,199,577.37134,932,783.6971,865,040.4362,240,958.73
  投资支付的现金---17,506,288
  支付其他与投资活动有关的现金---15,287,500
  投资活动现金流出小计218,199,577.37134,932,783.6971,865,040.4395,034,746.73
  投资活动产生的现金流量净额-213,532,547.37-130,666,953.39-67,865,040.4-371,462,955.88
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,350,0002,120,0001,200,000-
  其中:子公司吸收少数股东投资收到的现金2,350,0001,200,0001,200,000-
  取得借款收到的现金925,377,211.55723,180,822.66554,280,822.661,848,603,897.03
  收到其他与筹资活动有关的现金137,232,748.2393,684,715.963,184,715.9243,501,121.56
  筹资活动现金流入小计1,064,959,959.78818,985,538.56618,665,538.562,092,105,018.59
  偿还债务支付的现金1,045,865,317.98646,885,940.8548,886,048.681,856,791,501.47
  分配股利、利润或偿付利息支付的现金130,142,732.28111,485,874.3418,831,781.34160,961,290.05
  支付其他与筹资活动有关的现金107,594,110.6657,905,286.6845,716,861.96114,245,773.91
  筹资活动现金流出小计1,283,602,160.92816,277,101.82613,434,691.982,131,998,565.43
  筹资活动产生的现金流量净额-218,642,201.142,708,436.745,230,846.58-39,893,546.84
四、汇率变动对现金及现金等价物的影响-763,289.29202,946.54633,007.933,650,995.71
五、现金及现金等价物净增加额-68,690,452.246,564,375.37-4,181,235.1590,718,430.18
  加:期初现金及现金等价物余额588,348,089.7588,348,089.7588,348,089.7497,629,659.52
  期末现金及现金等价物余额519,657,637.46594,912,465.07584,166,854.55588,348,089.7
补充资料:
  净利润-137,951,125.38-84,322,026.98
  资产减值准备--2,452,434.53-122,186,914.91
  固定资产和投资性房地产折旧-96,432,790.39-148,101,356.49
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-96,432,790.39-148,101,356.49
  无形资产摊销-20,190,815.44-37,371,773.53
  长期待摊费用摊销-2,578,316.05-4,690,683.98
  处置固定资产、无形资产和其他长期资产的损失--75,914.07--194,370.44
  固定资产报废损失-123,001.47-1,106,928.48
  公允价值变动损失-35,990.75--
  财务费用-42,333,865.37-72,031,417.49
  投资损失-1,228,413.97-1,269,364.34
  递延所得税--17,501,500.57--25,070,708.02
  其中:递延所得税资产减少--1,808,158.78--21,157,076.04
    递延所得税负债增加--15,693,341.79--3,913,631.98
  存货的减少--31,389,516.19-15,154,847.18
  经营性应收项目的减少--110,970,386.47--26,285,712.1
  经营性应付项目的增加--18,257,801.28-37,078,896.85
  其他-13,155,723.44-18,240,926.21
  现金的期末余额-594,912,465.07-588,348,089.7
  减:现金的期初余额-588,348,089.7-497,629,659.52
  现金及现金等价物的净增加额-6,564,375.37-90,718,430.18
公告日期2025-10-302025-07-312025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑